News
June 27, 2023

Study identifies risk factors for early onset colorectal cancer in males

Presence of risk factors can identify younger men for whom early screening should be considered

INDIANAPOLIS – Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but are increasing for those under 50.

A new study, led by researcher-clinician Thomas Imperiale, M.D., of the U.S. Department of Veterans Affairs, Regenstrief Institute and Indiana University School of Medicine, identifies seven risk factors for early onset colorectal cancer in males. The risk evaluation model the researchers developed may help 45- to 49-year-olds accept and adhere to new national screening recommendations and may also identify younger men for whom earlier screening should be considered.

“This study is important because it puts whether, and possibly how, to screen people who are younger than age 45 — below the age for recommended colorectal cancer screening and have some of the risk factors we identify — on the table for consideration for screening,” said Dr. Imperiale.

“We know that colon cancer at younger ages is on the rise, although the absolute risk is still much lower than even in the 45- to 54-year-old age group. Nonetheless, that doesn’t mean that we shouldn’t be trying to identify younger people at higher risk to screen them with some modality,” he said.

“Clinicians might have a discussion with a patient and say that although screening guidelines don’t kick in until age 45 and you don’t have a family history, you do have some risk factors. Might you consider a noninvasive screening test? It could be fecal occult blood testing or multi-target stool DNA testing. It doesn’t have to be a colonoscopy. For men younger than 45 who are at higher-than-average risk, doing some type of screening would seem to make sense.

“When our study started it wasn’t clear whether the same set of risk factors for older folks would apply to those who were getting cancer at younger ages,” said Dr. Imperiale. “We found that while the weights assigned to some factors, such as family history and alcohol use, were about the same for men older and younger than 50, others, such as high body mass index (BMI) were risk factors for older but not younger men.”

The study of 600 individuals with non-hereditary colon or rectal cancer plus 2,400 control patients from VA medical centers across the U.S., used electronic health record data and national VA datasets to determine sociodemographic and lifestyle factors, family and personal medical history, physical measures, vital signs, medications and laboratory values for six to 18 months. All participants were male veterans between the ages of 35 and 49. A total of 65 percent were White and 30 percent were Black.

Initially identifying 15 variables associated with early onset colorectal cancer, the researchers subsequently condensed the prediction model to seven factors that provide similar precision and would be easier to use in clinical practice to estimate relative risk.

The seven factors conveying higher-than-average risk for early onset colorectal cancer in males are:

  • older age (within the 35- to 49-year-old age range)
  • no regular use of non-steroidal anti-inflammatory drugs (such as aspirin or ibuprofen)
  • no regular use of statins
  • current alcohol use
  • first or second degree relative with colorectal cancer
  • a higher disease burden
  • service-connection/copay variable – a marker for socio-economic status

“We don’t believe that any of these risk factors, with the exception of service-connection/copay variable, which we believe may be a proxy for income and/or socioeconomic status (and only an approximate one), are unique or specific to the veteran population,” said Dr. Imperiale.

He is currently analyzing data on risk factors for early onset colorectal cancer in female veterans. The risk of colorectal cancer is twice as high for men as for women in any age category.

Risk Factors for Early Onset Sporadic Colorectal Cancer in Male Veterans” is published in the peer-reviewed journal Cancer Prevention Research.

The study was funded by Health Services Research and Development, Veterans Health Administration (IIR 14-011) of the U.S. Department of Veterans Affairs.

Authors and their affiliations
Thomas F. Imperiale1-3, Laura J. Myers1, Barry C. Barker1, Jason Larson1, Timothy E. Stump4, and Joanne K. Daggy4

1Center of Innovation, Health Services Research and Development, Richard L. Roudebush VA Medical Center
2Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine
3Regenstrief Institute, Inc.
4Department of Biostatistics, Indiana University School of Medicine

About Thomas Imperiale, M.D.
In addition to his role as a research scientist at Regenstrief Institute, Thomas F. Imperiale, M.D., is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. He is a Distinguished Professor and the Lawrence Lumeng Professor of Gastroenterology and Hepatology at Indiana University School of Medicine as well.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

About Richard L. Roudebush Veterans Affairs (VA) Medical Center
Established in 1932, the Richard L. Roudebush VA Medical Center serves Veterans from across Indiana and western Illinois. The Roudebush VAMC is one of the largest and most complex medical centers in the Department of Veterans Affairs, and provides acute inpatient medical, surgical, psychiatric, rehabilitation, and neurological care to more than 60,000 Veterans annually. Some of the many services available to Veterans include emergency medicine, primary care, cardiac care, radiation oncology, audiology, community-based extended care and community VA clinics.

About IU School of Medicine
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

Related News

Kurt Kroenke, MD

The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

Published in the Journal of Pain. Here is a link to the article.  Regenstrief Institute authors:  Kurt Kroenke, PhD 

Shaun Grannis and Brian Dixon

Latest booster reduces adults’ risk of moderate or severe COVID by more than half

The most recent COVID-19 booster shot reduces adults’ risk of moderate or severe COVID by more than half, according

April Savoy, PhD

Closing the referral loop: perspectives and experiences of primary care and specialist physicians

INDIANAPOLIS – Every year, millions of referrals are made by primary care physicians in the U.S. for patients needing